S&P 500   4,577.11
DOW   35,368.47
QQQ   370.55
S&P 500   4,577.11
DOW   35,368.47
QQQ   370.55
S&P 500   4,577.11
DOW   35,368.47
QQQ   370.55
S&P 500   4,577.11
DOW   35,368.47
QQQ   370.55

Chemed Stock Forecast, Price & News

-6.66 (-1.37%)
(As of 01/18/2022 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
56,754 shs
Average Volume
51,011 shs
Market Capitalization
$7.53 billion
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive CHE News and Ratings via Email

Sign-up to receive the latest news and ratings for Chemed and its competitors with MarketBeat's FREE daily newsletter.

Chemed logo

About Chemed

Chemed Corp. engages in the provision of healthcare and maintenance services. It operates through the VITAS and Roto-Rooter segments. The VITAS segment offers hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers. The Roto-Rooter segment includes plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers. The company was founded in 1970 and is headquartered in Cincinnati, OH.


Chemed Co. (NYSE:CHE) Director Sells $266,215.00 in Stock
December 29, 2021 |  insidertrades.com
See More Headlines

Industry, Sector and Symbol

Home health care services
Health Care Services
Year Founded

Sales & Book Value

Annual Sales
$2.08 billion
Cash Flow
$21.85 per share
Book Value
$56.49 per share


Net Income
$319.47 million
Pretax Margin




Free Float
Market Cap
$7.53 billion

Company Calendar

Last Earnings
Ex-Dividend for 12/6 Dividend
Dividend Payable
Next Earnings (Estimated)
Fiscal Year End

Social Links


Overall MarketRank

2.62 out of 5 stars

Medical Sector

83rd out of 1,414 stocks

Home Health Care Services Industry

4th out of 9 stocks

Analyst Opinion: 2.5Community Rank: 4.1Dividend Strength: 3.3Insider Behavior: 2.5Valuation: 0.6 5 -4 -3 -2 -1 -

Chemed (NYSE:CHE) Frequently Asked Questions

Is Chemed a buy right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Chemed in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Chemed stock.
View analyst ratings for Chemed
or view top-rated stocks.

How has Chemed's stock price been impacted by COVID-19 (Coronavirus)?

Chemed's stock was trading at $414.05 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, CHE shares have increased by 15.7% and is now trading at $478.86.
View which stocks have been most impacted by COVID-19

When is Chemed's next earnings date?

Chemed is scheduled to release its next quarterly earnings announcement on Tuesday, February 22nd 2022.
View our earnings forecast for Chemed

How were Chemed's earnings last quarter?

Chemed Co. (NYSE:CHE) announced its earnings results on Thursday, October, 28th. The company reported $5.06 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $4.49 by $0.57. The business earned $538.67 million during the quarter, compared to analyst estimates of $531.87 million. Chemed had a trailing twelve-month return on equity of 35.68% and a net margin of 14.43%. The business's quarterly revenue was up 2.0% compared to the same quarter last year. During the same quarter in the previous year, the business posted $4.86 EPS.
View Chemed's earnings history

How often does Chemed pay dividends? What is the dividend yield for Chemed?

Chemed announced a quarterly dividend on Friday, November 5th. Shareholders of record on Monday, November 15th will be paid a dividend of $0.36 per share on Monday, December 6th. This represents a $1.44 annualized dividend and a dividend yield of 0.30%. The ex-dividend date is Friday, November 12th.
View Chemed's dividend history

Is Chemed a good dividend stock?

Chemed pays an annual dividend of $1.44 per share and currently has a dividend yield of 0.30%. Chemed has been increasing its dividend for 14 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio of Chemed is 7.57%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Chemed will have a dividend payout ratio of 7.40% next year. This indicates that Chemed will be able to sustain or increase its dividend.
View Chemed's dividend history.

What guidance has Chemed issued on next quarter's earnings?

Chemed updated its FY 2021 earnings guidance on Thursday, November, 4th. The company provided EPS guidance of $19.000-$19.200 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $17.910. The company issued revenue guidance of -.

What price target have analysts set for CHE?

2 equities research analysts have issued twelve-month target prices for Chemed's stock. Their forecasts range from $580.00 to $609.00. On average, they anticipate Chemed's stock price to reach $594.50 in the next year. This suggests a possible upside of 24.1% from the stock's current price.
View analysts' price targets for Chemed
or view top-rated stocks among Wall Street analysts.

Who are Chemed's key executives?

Chemed's management team includes the following people:
  • Kevin J. McNamara, President, Chief Executive Officer & Director (LinkedIn Profile)
  • David Patrick Williams, Chief Financial Officer & Executive Vice President
  • Spencer S. Lee, Executive Vice President
  • Nicholas M. Westfall, Executive Vice President
  • Thomas C. Hutton, Director & Vice President

What is Kevin J. McNamara's approval rating as Chemed's CEO?

1 employees have rated Chemed CEO Kevin J. McNamara on Glassdoor.com. Kevin J. McNamara has an approval rating of 100% among Chemed's employees. This puts Kevin J. McNamara in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Chemed own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Chemed investors own include AT&T (T), Home Depot (HD), Johnson & Johnson (JNJ), AbbVie (ABBV), Abbott Laboratories (ABT), CVS Health (CVS), Boeing (BA), UnitedHealth Group (UNH), Verizon Communications (VZ) and Chevron (CVX).

What is Chemed's stock symbol?

Chemed trades on the New York Stock Exchange (NYSE) under the ticker symbol "CHE."

Who are Chemed's major shareholders?

Chemed's stock is owned by a number of institutional and retail investors. Top institutional investors include Copeland Capital Management LLC (0.86%), Riverbridge Partners LLC (0.63%), Trinity Street Asset Management LLP (0.27%), Fenimore Asset Management Inc. (0.17%), Miracle Mile Advisors LLC (0.04%) and State of Alaska Department of Revenue (0.04%). Company insiders that own Chemed stock include Andrea R Lindell, Donald E Saunders, Kevin J Mcnamara, Michael D Witzeman, Naomi C Dallob, Nicholas Michael Westfall, Patrick P Grace, Spencer S Lee and Thomas P Rice.
View institutional ownership trends for Chemed

Which institutional investors are selling Chemed stock?

CHE stock was sold by a variety of institutional investors in the last quarter, including Trinity Street Asset Management LLP, State of Alaska Department of Revenue, Crossmark Global Holdings Inc., and Miracle Mile Advisors LLC. Company insiders that have sold Chemed company stock in the last year include Donald E Saunders, Kevin J Mcnamara, Nicholas Michael Westfall, Spencer S Lee, and Thomas P Rice.
View insider buying and selling activity for Chemed
or view top insider-selling stocks.

Which institutional investors are buying Chemed stock?

CHE stock was purchased by a variety of institutional investors in the last quarter, including Fenimore Asset Management Inc., Copeland Capital Management LLC, Riverbridge Partners LLC, LRT Capital Management LLC, IFP Advisors Inc, Exchange Traded Concepts LLC, and Spire Wealth Management.
View insider buying and selling activity for Chemed
or or view top insider-buying stocks.

How do I buy shares of Chemed?

Shares of CHE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Chemed's stock price today?

One share of CHE stock can currently be purchased for approximately $478.86.

How much money does Chemed make?

Chemed has a market capitalization of $7.53 billion and generates $2.08 billion in revenue each year. The company earns $319.47 million in net income (profit) each year or $19.03 on an earnings per share basis.

How many employees does Chemed have?

Chemed employs 15,544 workers across the globe.

When was Chemed founded?

Chemed was founded in 1970.

What is Chemed's official website?

The official website for Chemed is www.chemed.com.

Where are Chemed's headquarters?

How can I contact Chemed?

Chemed's mailing address is 255 EAST FIFTH STREET SUITE 2600, CINCINNATI OH, 45202. The company can be reached via phone at (513) 762-6690 or via fax at 513-762-6590.

This page was last updated on 1/19/2022 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.